Supports short-term, interventional exploratory clinical trials including proof-of-concept, Phase I, and Phase II studies in arthritis, musculoskeletal, and skin diseases. Research may involve drugs, biologics, devices, behavioral interventions, or physical therapy, aiming to translate promising research into clinical practice and improve patient outcomes.
Eligible applicants include a wide range of organizations such as state and local governments, tribal governments, nonprofits, institutions of higher education, for-profit organizations, small businesses, and foreign institutions. Specific eligibility details are provided in the full announcement.
